Evidence map›Paper›PMID 11098467›Full record

ReviewMolecular biotechnology2000

Recombinant protein expression in Pichia pastoris.

J M Cregg, J L Cereghino, J Shi, D R Higgins

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biotechnology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 224 papers.

0numbers the graph read from it
0cells of the map it votes in
224citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

224 citing papers in PubMed.

  1. Production of isotope-labeled nanobody KN035 inMagnetic resonance letters · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Yeast Midas' touch: recent advances in the valorisation of methanol by yeasts.World journal of microbiology & biotechnology · 2025
    Review
  9. Harnessing glycerol for secondary metabolite biosynthesis in microorganisms.World journal of microbiology & biotechnology · 2025
    Review
  10. Article
  11. Article
  12. Production of high-affinity glycosylated anti-mouse conjugated nanobodies inFrontiers in bioengineering and biotechnology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

164 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

J M CreggKeck Graduate Institute of Applied Life Sciences, Claremont, CA 91711, USA. James_Cregg@kgi.edu
J L Cereghino
J Shi
D R Higgins

Funding

PEROXISOME BIOGENESIS IN YEASTR01DK043698 · NIDDK · OREGON HEALTH AND SCIENCE UNIVERSITY · PI CREGG, JAMES MICHAEL · 1992 to 2000
$231k
NIDDK NIH HHS DK-43698
6 · The paper itself

Abstract

The methylotrophic yeast Pichia pastoris is now one of the standard tools used in molecular biology for the generation of recombinant protein. P. pastoris has demonstrated its most powerful success as a large-scale (fermentation) recombinant protein production tool. What began more than 20 years ago as a program to convert abundant methanol to a protein source for animal feed has been developed into what is today two important biological tools: a model eukaryote used in cell biology research and a recombinant protein production system. To date well over 200 heterologous proteins have been expressed in P. pastoris. Significant advances in the development of new strains and vectors, improved techniques, and the commercial availability of these tools coupled with a better understanding of the biology of Pichia species have led to this microbe's value and power in commercial and research labs alike.

Indexed as

Alcohol OxidoreductasesAnimalsCloning, MolecularFermentationGenetic VectorsGenotypeHumansMolecular BiologyPhenotypePichiaRecombinant Proteinsalcohol oxidaseAlcohol OxidoreductasesRecombinant Proteins

Identifiers

PMID11098467

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.